Inventor · disambiguated record
Peter Dove
Also filed as: DOVE PETER · DOVE PETER MARTIN
9 granted patents·18 pending applications·10 citations·filing 2006–2023
80Inventor score
Files withTRILLIUM THERAPEUTICS INC7ASTRAZENECA AB6CANOPY GROWTH CORP4NPS PHARMA INC3FLUORINOV PHARMA INC2
Top patents by PatentIndex Score
27 records- 0183US10259809B2Fluorinated imidazo[4,5-C]quinoline derivatives as inhibitors of bromodomain containing proteinsTRILLIUM THERAPEUTICS INC·Filed 2016·Granted Apr 16, 2019·2 cites·24 claims
- 0275US7772235B2mGluR5 modulatorsASTRAZENECA AB·Filed 2007·Granted Aug 10, 2010·2 cites·6 claims
- 0372US9441012B2Fluorinated epoxyketone-based compounds and uses thereof as proteasome inhibitorsFLUORINOV PHARMA INC·Filed 2013·Granted Sep 13, 2016·3 cites·30 claims
- 0469US8618286B2Benzoxazines, benzothiazines, and related compounds having NOS inhibitory activityRAMNAUTH JAILALL·Filed 2012·Granted Dec 31, 2013·2 cites·26 claims
- 0567US8173813B2Quinolone and tetrahydroquinolone and related compounds having NOS inhibitory activityMADDAFORD SHAWN·Filed 2008·Granted May 8, 2012·1 cites·17 claims
- 0664US10696670B2Fluorinated imidazo[4,5-C]quinoline derivatives as inhibitors of bromodomain containing proteinsTRILLIUM THERAPEUTICS INC·Filed 2019·Granted Jun 30, 2020·0 cites·18 claims
- 0761US2024158350A1Ester analogs of psilocin, processes for the preparation thereof, and methods of useINVYXIS INC·Filed 2023·Application pending·0 cites
- 0859US8106043B2Benzoxazines, benzothiazines, and related compounds having NOS inhibitory activityRAMNAUTH JAILALL·Filed 2009·Granted Jan 31, 2012·0 cites·25 claims
- 0954US2014163016A1Benzoxazines, benzothiazines, and related compounds having nos inhibitory activityNEURAXON INC·Filed 2013·Application pending·0 cites
- 1052US2008312240A1Bicyclic Piperazines as Metabotropic Glutatmate Receptor AntagonistsASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 1152US2007037816A1Bicyclic piperazines as metabotropic glutatmate receptor antagonistsNPS PHARMA INC·Filed 2006·Application pending·0 cites
- 1251US2007037817A1Acetylenic piperazines as metabotropic glutamate receptor antagonistsNPS PHARMA INC·Filed 2006·Application pending·0 cites
- 1350US2008194571A1Acetylenic Piperazines as Metabotropic Glutamate Receptor AntagonistsASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 1448US2007049578A1Cinnamamide compounds as metabotropic glutamate receptor antagonistsNPS PHARMA INC·Filed 2006·Application pending·0 cites
- 1546US2009111857A11,2,4-triazole ether derivatives as modulators of mglur5ASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 1646US2023122510A1Cannabinoid derivativesCANOPY GROWTH CORP·Filed 2020·Application pending·0 cites
- 1745US12195429B2Cannabinoid derivativesCANOPY GROWTH CORP·Filed 2020·Granted Jan 14, 2025·0 cites·2 claims
- 1845US2022242856A1Cannabinoid derivativesCANOPY GROWTH CORP·Filed 2020·Application pending·0 cites
- 1944US12325709B2Cannabinoid derivativesCANOPY GROWTH CORP·Filed 2020·Granted Jun 10, 2025·0 cites·20 claims
- 2044US2007259895A1MGluR5 modulators VIASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 2144US2016347792A1Fluorinated epoxyketone-based compounds and uses thereof as proteasome inhibitorsTRILLIUM THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2244US2007259860A1MGluR5 modulators VASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 2340US2015218212A1Fluorinated epoxyketone-based tetrapeptide compounds and uses thereof as proteasome inhibitorsFLUORINOV PHARMA INC·Filed 2013·Application pending·0 cites
- 2438US2019016689A1Novel fluorinated quinazoline derivatives as egfr inhibitorsTRILLIUM THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 2537US2020031825A1Heteroaromatic-fused imidazolyl amides, compositions and uses thereof as sting agonistsTRILLIUM THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2636US2018050993A1Novel fluorinated derivatives as egfr inhibitors useful for treating cancersTRILLIUM THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2735US2018016227A1Process for the synthesis of difluoromethyl ether-based compoundsTRILLIUM THERAPEUTICS INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Peter Dove files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →